In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein-Cannulated Rats
β Scribed by Matsuda, Y.; Konno, Y.; Hashimoto, T.; Nagai, M.; Taguchi, T.; Satsukawa, M.; Yamashita, S.
- Book ID
- 121868133
- Publisher
- American Society for Pharmacology and Experimental Therapeutics
- Year
- 2013
- Tongue
- English
- Weight
- 984 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0090-9556
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The utility of the diaminoquinazoline derivative CP-100,356 as an in vivo probe to selectively assess MDR1/BCRP-mediated drug efflux was examined in the rat. CP-100,356 was devoid of inhibition (IC 50 >50 mM) against major human P450 enzymes including P4503A4. In human MDR1-transfected MDCKII cells,
The contribution of lymphatic transport and absorption directly into the portal blood to the overall oral bioavailability of a model lipophilic drug, halofantrine (Hf), was determined in lymph-cannulated, conscious, unrestrained rats after administration in lipidic vehicles with different fatty acid
The absorptive (AQ) and secretory (SQ) quotients have been proposed as a novel experimental approach to quantify the modulation of intestinal absorption and secretion by P-glycoprotein (Pgp). Because these unidirectional assays inherently assess for the impact of Pgp, conclusions as to whether a com